Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man
LR Fischer, DG Culver, P Tennant, AA Davis… - Experimental …, 2004 - Elsevier
The SOD1 mutant mouse is the most widely used model of human amyotrophic lateral sclerosis
(ALS). To determine where and when the pathological changes of motor neuron disease …
(ALS). To determine where and when the pathological changes of motor neuron disease …
Novel selective allosteric activator of the M1 muscarinic acetylcholine receptor regulates amyloid processing and produces antipsychotic-like activity in rats
Recent studies suggest that subtype-selective activators of M 1 /M 4 muscarinic acetylcholine
receptors (mAChRs) may offer a novel approach for the treatment of psychotic symptoms …
receptors (mAChRs) may offer a novel approach for the treatment of psychotic symptoms …
A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in …
JK Shirey, AE Brady, PJ Jones, AA Davis… - Journal of …, 2009 - Soc Neuroscience
M 1 muscarinic acetylcholine receptors (mAChRs) may represent a viable target for treatment
of disorders involving impaired cognitive function. However, a major limitation to testing …
of disorders involving impaired cognitive function. However, a major limitation to testing …
[HTML][HTML] CSF tau microtubule-binding region identifies pathological changes in primary tauopathies
Despite recent advances in fluid biomarker research in Alzheimer’s disease (AD), there are
no fluid biomarkers or imaging tracers with utility for diagnosis and/or theragnosis available …
no fluid biomarkers or imaging tracers with utility for diagnosis and/or theragnosis available …
[HTML][HTML] Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins: Thematic Review Series: ApoE …
TPV Huynh, AA Davis, JD Ulrich, DM Holtzman - Journal of lipid research, 2017 - ASBMB
Alzheimer's disease (AD) is one of the fastest-growing causes of death and disability in
persons 65 years of age or older, affecting more than 5 million Americans alone. Clinical …
persons 65 years of age or older, affecting more than 5 million Americans alone. Clinical …
Wlds mice are resistant to paclitaxel (taxol) neuropathy
MS Wang, AA Davis, DG Culver… - Annals of Neurology …, 2002 - Wiley Online Library
The Wld S mouse is a unique mutant strain that demonstrates the remarkable phenotype of
prolonged survival of transected axons (“slow Wallerian degeneration”). In these studies, we …
prolonged survival of transected axons (“slow Wallerian degeneration”). In these studies, we …
A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors
…, DPD Woldbye, Y Cui, AA Davis… - Journal of …, 2010 - Soc Neuroscience
Acetylcholine (ACh) regulates many key functions of the CNS by activating cell surface
receptors referred to as muscarinic ACh receptors (M 1 –M 5 mAChRs). Like other mAChR …
receptors referred to as muscarinic ACh receptors (M 1 –M 5 mAChRs). Like other mAChR …
An astrocyte BMAL1-BAG3 axis protects against alpha-synuclein and tau pathology
The circadian clock protein BMAL1 modulates glial activation and amyloid-beta deposition in
mice. However, the effects of BMAL1 on other aspects of neurodegenerative pathology are …
mice. However, the effects of BMAL1 on other aspects of neurodegenerative pathology are …
Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo
Alzheimer's disease (AD) is a progressive neurological disorder that causes dementia and
poses a major public health crisis as the population ages. Aberrant processing of the amyloid …
poses a major public health crisis as the population ages. Aberrant processing of the amyloid …
APOE genotype regulates pathology and disease progression in synucleinopathy
Apolipoprotein E (APOE) ε4 genotype is associated with increased risk of dementia in
Parkinson’s disease (PD), but the mechanism is not clear, because patients often have a mixture …
Parkinson’s disease (PD), but the mechanism is not clear, because patients often have a mixture …